Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction - Aims and methods of the OMEGA-study

Cardiovascular Drugs and Therapy

Volumn 20, Issue 5, 2006, Pages 365-375

  Rauch, Bernhard ^a,b   Schiele, Rudolf ^a   Schneider, Steffen ^b   Gohlke, Helmut ^c   Diller, Frank ^b   Gottwik, Martin ^d   Steinbeck, Gerhard ^e   Heer, Tobias ^a   Katus, Hugo ^f   Zimmer, Reinhilde ^g   Erdogan, Ali ^h   Pfafferott, Conrad ⁱ   Senges, Jochen ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b Foundation Stiftung Institut für Herzinfarktforschung   (Germany)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d KLINIKUM NÜRNBERG   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY HOSPITAL GIESSEN   (Germany)

ⁱ KLINIKUM INGOLSTADT   (Germany)

Author keywords

Beck depression inventory; Depression; Holter monitoring; Myocardial infarction; Omega 3 fatty acids; Omega 3 acid ethyl esters 90; Secondary prevention; Sudden cardiac death

Indexed keywords

DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; ZODIN;

ADULT; ADVERSE OUTCOME; ARTICLE; BECK DEPRESSION INVENTORY; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG PURIFICATION; DRUG SAFETY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE REVASCULARIZATION; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SECONDARY PREVENTION; STANDARD; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; DEPRESSION; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FATTY ACIDS, OMEGA-3; FEMALE; HEART; HEART RATE; HUMANS; MALE; MYOCARDIAL INFARCTION;

EID: 33845611041     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-006-0495-6     Document Type: Article

References (63)

1. Bang HO, Dyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Escimos. Lancet 1971;1 7710:1143-5.
2. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004;93 9:1119-23.
3. Albert CM, Hennekens CH, O'Donnel CJ, Ajani UA, Carey VJ, Willet, WC et al. Fish consumption and risk of sudden cardiac death. JAMA 1998;279 1:23-8.
4. Daviglus MI, Stamler J, Orencia AJ, Ryder AR, Lu K, Greenland P, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997;336 15:1046-53.
5. Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med 1992;200 2:177-82.
6. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287 14:1815-21.
7. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracey RP, Siscovick DS et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003;107 10:1372-7.
8. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and eicosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000;102:2677-9.
9. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetram PM et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-61.
10. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
11. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903.
12. de Vreede JJ, Gorgels AP, Verstraaten GM, Vermeer F, Dassen WR, Wellens HJ. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 1991;18:698-706.
13. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt A, Boersma E et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002;23 15:1190-201.
14. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353 9164:1547-57.
15. Lorenz H, Junger C, Seidl K, Gitt A, Schneider S, Schiele R et al. Do statins influence the prognostic impact of nonsustained ventricular tachycardia after ST-elevation myocardial infarction? Eur Heart J 2005;26 11:1078-85.
16. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003;57:193-200.
17. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005;293:2884-91.
18. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006;113:195-202.
19. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ et al. Risks and benefits of omega-3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006;332:752-60 (Epub 2006 Mar 24).
20. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 1999;99:2452-7.
21. Dhein S, Michaelis B, Mohr FW. Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. Naunyn Schmiedebergs Arch Pharmacol 2005;371:202-11 (Epub 2005 Apr 15).
22. McLennan PL, Abeywardena MY, Charnock JS. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharm 1985;63:1411-7.
23. Xiao YF, Ke Q, Wang SY, Auktor K, Yang Y, Kuo G et al. Single point mutations affect fatty acid block of human myocardial sodium channel alpha-subunit Na+ channels. Proc Natl Acad Sci U S A 2001;98:3606-11.
24. Macleod JC, Macknight AD, Rodrigo GC. The electrical and mechanical response of adult guinea pig and rat ventricular myocytes to omega3 polyunsaturated fatty acids. Eur J Pharmacol 1998;356:261-70.
25. Kang JX, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies. Circulation 1996;94:1774-80.
26. Kang JX, Leaf A. Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. Proc Natl Acad Sci U S A 1996;93:3542-6.
27. Hallaq H, Sellmayer A, Smith TW, Leaf A. Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 1990;87:7834-8.
28. Hallaq H, Smith TW, Leaf A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U S A 1992;89:1760-4.
29. Honore E, Barhanin J, Attali B, Lesage F, Lazdunski M. External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids. Proc Natl Acad Sci U S A 1994;91:1937-41.
30. O'Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006;97:1127-30.
31. Christensen JH, Gustenhoff P, Korup E, Aaroe J, Toft E, Moller T et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 1996;312:677-8
32. Christensen JH, Korup E, Aaroe J, Toft E, Moller J, Rasmussen K et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997;79:1670-3.
33. Christensen JH, Christensen MS, Dyerberg J, Schmidt EB. Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr 1999;70:331-7.
34. Schrepf R, Limmert T, Claus Weber P, Theisen K, Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004;363:1441-2.
35. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005;112:2762-8.
36. Ahmed K, Thomas S. The effects of long chain fatty acids on sodium plus potassium ion-stimulated adenosine triphosphatase of rat brain. J Biol Chem 1971;246:103-9.
37. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 1984;55:135-54.
38. Fiehn W, Hasselbach W. The effect of phospholipase A on the calcium transport and the role of unsaturated fatty acids in ATPase activity of sarcoplasmic vesicles. Eur J Biochem 1970;13:510-8.
39. Lamers JM, Hulsmann WC. Inhibition of (Na++K+)-stimulated ATPase of heart by fatty acids. J Mol Cell Cardiol 1977;9:343-6.
40. Messineo FC, Rathier M, Favreau C, Watras J, Takenaka H. Mechanisms of fatty acid effects on sarcoplasmic reticulum. III. The effects of palmitic and oleic acids on sarcoplasmic reticulum function - a model for fatty acid membrane interactions. J Biol Chem 1984;259:1336-43.
41. Rauch B, Colvin RA, Messineo FC. Inhibition of 3H-quinuclidinyl benzylate binding to cardiac muscarinic receptor by long chain fatty acids can be attenuated by ligand occupation of the receptor. J Mol Cell Cardiol 1989;21:495-506.
42. Rauch B, Niroomand F, Messineo FC, Weis A, Kubler W, Hasselbach W. Effect of phospholipid hydrolysis by phospholipase A2 on the kinetics of antagonist binding to cardiac muscarinic receptors. Biochem Pharmacol 1994;48:1289-96.
43. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996;31 Suppl:S157-61.
44. Edwards R, Peet M, Shay J, Horrobin D. Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients. Biochem Soc Trans 1998;26:S142.
45. Horrobin DF. Phospholipid-metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase. Hum Psychopharmacol 2001;16:45-52.
46. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999;85:275-91.
47. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998;43:315-9.
48. Mischoulon D, Fava M. Docosahexaenoic acid and omega-3 fatty acids in depression. Psychiatr Clin North Am 2000;23:785-94.
49. Puri BK, Counsell SJ, Hamilton G, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid-turnover. Int J Clin Pract 2001;55:560-3.
50. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E et al. Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-12.
51. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. impact on 6-month survival. JAMA 1993;270:1819-25.
52. Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 1999;61:26-37.
53. Kaufmann MW, Fitzgibbons JP, Sussman EJ, Reed JF 3rd, Einfalt JM, Rodgers JK et al. Relation between myocardial infarction, depression, hostility and death. Am Heart J 1999;138:549-54.
54. Ladwig KH, Roll G, Breithardt G, Budde T, Borggrefe M. Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994;343:20-3.
55. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001;88:337-41.
56. Carney RM, Rich MW, Tevelde AJ, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol 1987;60:1273-5.
57. Beck AT, Brown GK, Steer RA. Beck depression inventory - II (BDI-II). San Antonio: The Psychological Corporation; 1996.
58. Hautzinger M, Keller F, Kühner C, Bürger C. Beck depression inventar II (BDI 2). Bern: Hans Huber Verlag; 2005.
59. Fleiss JL. Statistical methods for rates and proportions. Weinheim: Wiley, 1981; pp. 38-42.
60. Wienbergen H, Gitt AK, Schiele R, Juenger C, Heer T, Gottwik M et al. (for the ACOS Study Group). Actual clinical practice of exercise testing in consecutive patients after non-ST-elevation myocardial infarction - results of the Acute Coronary Syndromes Registry (ACOS). Eur J Card Prev Rehab 2006;13:457-63.
61. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KAA et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European society of cardiology. Eur Heart J 2003;24:28-66.
62. Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, Wever EF et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators - The study on omega-3 fatty acids and ventricular arrhythmias (SOFA) randomized trial. JAMA 2006;295:2613-9.
63. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006;84:5-17.